Mongoose Bio CEO, Neil Warma, to Speak at Premier UAE Healthcare Leadership Events – Highlighting Biotech Innovations and Global Partnerships for Transformative Healthcare
Houston, Texas, September 16, 2024 – Mongoose Bio, a clinical-stage biopharmaceutical company advancing next-generation precision T-cell therapies for solid cancers, announced today that its President and CEO, Neil Warma, will serve as a distinguished speaker at two high-profile healthcare summits in the United Arab Emirates this September.
Event 1: Abu Dhabi: Forbes Healthcare Leaders Summit
September 19, 2024 at 11:05-11:20 AM: Mr. Warma will speak on the main stage on Biotech Breakthroughs Revolutionizing Personalized Healthcare. Experts will deep dive into cutting-edge biotech innovations that are transforming personalized healthcare, highlighting how breakthroughs in gene editing, biotechnology, and precision medicine are reshaping patient care and treatment outcomes.
The Forbes Middle East Healthcare Leaders Summit brings together leading experts, visionaries, and influencers from the healthcare industry with the aim of advancing and enhancing healthcare across the region. Through innovative discussions, thought-provoking panels, and interactive sessions, the summit pioneers the future of sustainable healthcare, promoting collaboration, innovation, and healing.
Event 2: September, 21, 2024 in Dubai: 10th edition of the Integrated Health and Wellbeing (IHW) Summit & Global Leaders Awards
September 21, 2024:
11:15-12:00: Mr. Warma will participate on a panel entitled: Harnessing Digital Health & Pharma Tech for Global Healthcare Equity
12:20-1:20: Mr. Warma will host a panel on the topic: United for Health: Transforming Global Health through Healthcare Partnerships
As a premier advocacy think tank, the Integrated Health & Wellbeing (IHW) Council stands at the forefront of promoting human health and overall well-being in the region. Embracing the foundational principles of the “High Five of Health,” which emphasize the importance of Good Air, Good Water, Good Food, Good Lifestyle, and Good Healthcare for all, the Council has emerged as a leading advocate for holistic health approaches.
“I am honored to join global leaders at these distinguished events to highlight the transformative potential of precision medicine and collaborative innovation,” said Mr. Warma. “As Mongoose Bio advances the next generation of T-cell therapies, we are committed to redefining patient outcomes and contributing to a more equitable global healthcare ecosystem.”
About Mongoose Bio
Mongoose Bio is a clinical-stage biopharmaceutical company dedicated to developing advanced cellular immunotherapies for solid cancers. The company’s proprietary Immunopeptidome Discovery Platform (IDP) and Epigenetic T Cell Reprogramming (ECMR) technologies drive next-generation adoptive TCR-T cell therapies with enhanced efficacy and durability. Learn more at www.mongoosebio.com.
Investor Relation & Media Contact:
Email: info@mongoosebio.com